IDH2 and astrocytoma (excluding glioblastoma): IDH-mutant astrocytomas usually receive radiotherapy in conjunction with adjuvant temozolomide (TMZ), whereas glioblastomas receive radiotherapy and either concurrent or adjuvant TMZ [3].